A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.

Clinical pharmacology in drug development2021Thai C, Tayo B, Critchley D

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2021
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdultAnticonvulsantsCaffeineCannabidiolCentral Nervous System StimulantsCytochrome P-450 CYP1A2Cytochrome P-450 CYP1A2 InhibitorsDrug InteractionsFemaleHumansMaleTheophyllineYoung Adult

DOI 10.1002/cpdd.950

PMID 33951339

View source →